Rhythm Pharmaceuticals, Inc.
RYTM
$115.48
-$0.54-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.15% | -20.12% | 24.58% | 25.73% | 29.42% |
| Total Depreciation and Amortization | -29.48% | -21.67% | -14.40% | -9.27% | -7.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.05% | 88.42% | -40.19% | -41.92% | -50.67% |
| Change in Net Operating Assets | -134.20% | -307.46% | -109.15% | 7.06% | 284.55% |
| Cash from Operations | 2.21% | -5.31% | -1.58% | 12.29% | 16.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,667.41% | -94.64% | -182.73% | -213.43% | 118.07% |
| Cash from Investing | -1,677.78% | -96.43% | -184.71% | -213.44% | 118.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 139.12% | 140.65% | 321.83% | 1,341.67% | 37.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.75% | -235.91% | -397.93% | -562.51% | -170.66% |
| Cash from Financing | 148.22% | -17.97% | 13.97% | 66.89% | -67.94% |
| Foreign Exchange rate Adjustments | 544.09% | 656.34% | 4,250.00% | 185.69% | 119.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | -- |
| Net Change in Cash | -168.68% | -183.20% | -219.14% | 128.14% | -156.41% |